This inventor holds 1 USPTO granted patent. Top assignee: University of Washington. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Jie An: Innovator in Therapeutic Strategies for Autoimmune Diseases
Introduction
Jie An is a prominent inventor based in Seattle, WA, known for his contributions to the field of therapeutic strategies for severe debilitating diseases. His innovative work focuses on the treatment of conditions associated with interferon type I (IFN-I) due to cGAS activation.
Latest Patents
Jie An holds a patent related to his invention titled "CGAS in systemic lupus erythematosus (SLE)." This patent provides therapeutic strategies for treating autoimmune diseases and monogenic disorders. The invention includes compounds of Formula (I) and outlines pharmaceutical uses for these compounds. Additionally, it describes methods for administering effective amounts of these compounds to treat various conditions.
Career Highlights
Jie An is affiliated with the University of Washington, where he conducts research and develops innovative solutions in the medical field. His work has significant implications for patients suffering from autoimmune diseases, showcasing his commitment to advancing medical science.
Collaborations
Some of Jie An's notable coworkers include Keith B Elkon and Mark Minie, who contribute to the collaborative efforts in research and development within the university.
Conclusion
Jie An's innovative work in therapeutic strategies for autoimmune diseases highlights his role as a key inventor in the medical field. His contributions are paving the way for new treatments that can improve the quality of life for many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile